Shu-Ling Chiu

Johns Hopkins University School of Medicine, Baltimore, MD, United States 
neuronal development, circuit function, synaptic transmission, dendritic plasticity
"Shu-Ling Chiu"
Mean distance: 13.35 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mejias R, Chiu SL, Han M, et al. (2019) Purkinje cell-specific Grip1/2 knockout mice show increased repetitive self-grooming and enhanced mGluR5 signaling in cerebellum. Neurobiology of Disease. 104602
Wang Q, Chiu SL, Koropouli E, et al. (2017) Neuropilin-2/PlexinA3 Receptors Associate with GluA1 and Mediate Sema3F-Dependent Homeostatic Scaling in Cortical Neurons. Neuron
Chiu SL, Diering GH, Ye B, et al. (2017) GRASP1 Regulates Synaptic Plasticity and Learning through Endosomal Recycling of AMPA Receptors. Neuron
Chen CM, Orefice LL, Chiu SL, et al. (2017) Wnt5a is essential for hippocampal dendritic maintenance and spatial learning and memory in adult mice. Proceedings of the National Academy of Sciences of the United States of America
Han M, Mejias R, Chiu SL, et al. (2017) Mice lacking GRIP1/2 show increased social interactions and enhanced phosphorylation at GluA2-S880. Behavioural Brain Research
Gu Y, Chiu SL, Liu B, et al. (2016) Differential vesicular sorting of AMPA and GABAA receptors. Proceedings of the National Academy of Sciences of the United States of America
Zhang K, Donnelly CJ, Haeusler AR, et al. (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 525: 56-61
Volk L, Chiu SL, Sharma K, et al. (2015) Glutamate Synapses in Human Cognitive Disorders. Annual Review of Neuroscience. 38: 127-49
Ma R, Wang Y, Yan L, et al. (2015) Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin. Chemical Communications (Cambridge, England). 51: 7859-62
Ma L, Ma R, Wang Y, et al. (2015) Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(IV) prodrug with unique mode of action. Chemical Communications (Cambridge, England). 51: 6301-4
See more...